Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors
Conditions:   Gastrinoma;   Glucagonoma;   Insulinoma;   Metastatic Gastrointestinal Carcinoid Tumor;   Pancreatic Polypeptide Tumor;   Pulmonary Carcinoid Tumor;   Recurrent Gastrointestinal Carcinoid Tumor;   Recurrent Islet Cell Carcinoma;   SomatostatinomaInterventions:   Drug: regorafenib;   Other: laboratory biomarker analysisSponsors:   University of Southern California;   National Cancer Institute (NCI)Not yet recruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 3, 2014 Category: Research Source Type: clinical trials

RegisterNET - A Registry for Neuroendocrine Tumors in the USA
Conditions:   Neuroendocrine Tumor;   Carcinoid;   Neuroendocrine CarcinomaIntervention:   Device: NETestSponsor:   Wren Laboratories LLCRecruiting - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 29, 2014 Category: Research Source Type: clinical trials